Grundium schedules ROSE webinar May14

Digital cytology is one of those niche hospital workflow topics that sounds small until you see the bottleneck. ROSE — Rapid On-Site Evaluation — happens during procedures, when someone has to look at a fresh specimen right away and decide whether it is adequate or whether the clinician needs another pass. If that expert is not available, the whole process slows down. Grundium’s news this week is basically a webinar push around that exact problem: on May 14 it is backing a session focused on telecytology for ROSE and how labs can keep coverage going when staffing is stretched. ### What is ROSE, exactly? ROSE is the quick on-the-spot review of cytology material during procedures like fine needle aspirations and touch preparations of core biopsies. The immediate goal is not always a final diagnosis. It is often to confirm that the sample is good enough, flag obvious malignancy or infection, and help the team decide whether more material needs to be collected while the patient is still there. (britishcytology.org.uk) ### Why is staffing the real issue? Because ROSE is time-sensitive, the old model leans on having a cytopathologist or cytotechnologist available right when a case starts. That gets hard across multiple hospitals, smaller sites, or lean teams. Grundium’s own cited use cases lean hard on this pain point — remote hospitals, centralized pathology coverage, and budget or staffing constraints that make in-person coverage hard to sustain. (grundium.com) ### So what changed this week? The concrete update is the May 14 webinar listing. The British Association for Cytopathology page names the session “When ROSE Coverage Is Stretched: A Practical Digital Cytology Use Case,” and it says recent ASC survey data has made telecytology for ROSE one of the most important and widely recognized digital cytology applications. That gives the event a clear angle: this is not a broad “future of AI pathology” talk — it is a workflow discussion aimed at a specific operational headache. (grundium.com) ### Why is telecytology the proposed fix? Because it lets the slide stay local while the expertise moves. A technologist or staff member at the procedure site prepares the glass slide, captures images, and a pathologist reviews remotely. Grundium’s materials describe this as part of a broader digital pathology setup where the pathologist can cover multiple sites from a central location and get notified case by case. Basically, instead of moving people between hospitals, you move the image. (britishcytology.org.uk) ### What does Grundium actually sell into this? Portable slide scanners — the Ocus line. Grundium pitches them as compact digital pathology scanners built for remote consultation and image sharing, with remote access supported through VPN or its routing service. That matters here because telecytology only works if image capture is fast enough and simple enough to fit into a live procedural workflow. ### Is this just marketing, or is there a real use case? (grundium.com) There is a real use case underneath the marketing. Grundium has published a webinar recording from a March 20, 2025 session with Dr. Hannah Krigman of Washington University on “Using telecytology for ROSE,” and it points to a Washington University workflow where remote digital review supported ROSE across affiliate hospitals. A related poster summary says the setup enabled completely remote cytologic diagnosis for multiple sites without onsite pathologists or cytotechnologists. (grundium.com) ### What is the catch? Telecytology is not magic. Image quality still depends on slide prep, coverslips, and tissue thickness, and Grundium’s own materials stop short of claiming digital review replaces every conventional microscopy task. The practical promise is narrower — keep care moving, preserve specialist reach, and reduce the need for physical presence in every room. ### Bottom line? This story is really about pathology labor and coverage, not webinars. (grundium.com) The May 14 event matters because it shows where digital cytology adoption is getting traction first — not in abstract digitization plans, but in the very specific moment when a procedure is happening and nobody can wait. (britishcytology.org.uk) (grundium.com)